bioAffinity Technologies, Inc. (BIAFW) Free cash flow 2022–2025
bioAffinity Technologies, Inc. (BIAFW) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$9.4MFY2025 · since FY2022: -$4.3M → -$9.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.4M | -27.9% |
| FY2024 | -$7.3M | -21.2% |
| FY2023 | -$6.1M | -41.2% |
| FY2022 | -$4.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BIAFW financial trends
BIAFW RevenueBIAFW Net incomeBIAFW Net marginBIAFW Gross profitBIAFW Gross marginBIAFW Operating incomeBIAFW Operating marginBIAFW Operating cash flowBIAFW Capital expendituresBIAFW Return on equityBIAFW Stock buybacksBIAFW Dividends paidBIAFW Total assetsBIAFW Total liabilitiesBIAFW Shareholders’ equityBIAFW overview →